Home / 510(k) Clearances / K052825

510(k) K052825

VISULIZE FACTOR VIII ANTIGEN KIT, MODEL FVIII-AG by Affinity Biologicals, Inc. — Product Code GGP

K052825 is an FDA 510(k) premarket notification submitted by Affinity Biologicals, Inc. for the device "VISULIZE FACTOR VIII ANTIGEN KIT, MODEL FVIII-AG". The FDA issued a decision of Substantially Equivalent on January 20, 2006. The device falls under product code GGP (Test, Qualitative And Quantitative Factor Deficiency), a Class II device regulated under 21 CFR 864.7290. Affinity Biologicals, Inc. has at least 4 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
January 20, 2006
Date Received
October 5, 2005
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Test, Qualitative And Quantitative Factor Deficiency
Device Class
Class II
Regulation Number
864.7290
Review Panel
HE
Submission Type

Other clearances by Affinity Biologicals, Inc.

  • K150144 — VisuCon-F Low Fibrinogen Control Plasma (March 6, 2016)
  • K110432 — VISUCON-F FROZEN COAG SCREEN N, VISUCON-F FROZEN COAG SCREEN ABN (October 20, 2011)
  • K091284 — VISUCAL-F FROZEN CALIBRATOR PLASMA AND VISUCON-F FROZEN NORMAL AND ABNORMAL CONT (October 28, 2009)
  • K051054 — VISULIZE FACTOR IX ANTIGEN KIT (June 29, 2005)

Other clearances for product code GGP

  • K251440 — CRYOcheck Chromogenic Factor VIII (August 25, 2025)
  • K230852 — HemosIL Chromogenic Factor IX (December 13, 2023)
  • K220728 — vWF Ag (June 2, 2023)
  • K214002 — CRYOcheck Chromogenic Factor IX (December 23, 2022)
  • K223402 — HemosIL von Willebrand Factor Antigen (December 9, 2022)
  • K200033 — HemosIL von Willebrand Factor Antigen (August 19, 2020)
  • K193204 — Cryocheck Chromogenic Factor VIII (July 17, 2020)
  • K183440 — CRYOcheck FVIII Inhibitor Kit (March 12, 2019)
  • K181525 — INNOVANCE Free PS Ag (September 7, 2018)
  • K133005 — HEMOSIL VON WILLEBRAND ACTIVITY ASSAY (March 13, 2014)

FDA data resources